tradmap

ACA Financials Arcosa, Inc.

10 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 8.3% per year over the past 5 years.
  • Net income has grown faster than revenue (14.3% vs 8.3% per year).
  • Operating margin has expanded, at 11.9% in the latest year.
  • Free cash flow has declined 0.3% per year over the past 5 years.

Financial health

  • Operating income covered interest expense 3.1× in the latest year.

Shareholder returns

  • Dividends have been paid for 8 consecutive years, consuming 4.8% of earnings and 5.7% of free cash flow.
  • The dividend has grown 0.4% per year over the past 5 years.
Revenue & net income
$0 $1B $3B 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
RevenueNet income
Margins (gross / operating / net)
0% 11% 22% 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $156M $312M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Free cash flow
Cash vs total debt
$0 $120M $240M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$2B -$210M $1B $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $2.9B $208M 22.4% 11.9% $176M $215M
2024 $2.6B $94M 20.0% 7.7% $312M $187M
2023 $2.3B $159M 19.2% 9.4% $58M $105M
2022 $2.2B $246M 18.3% 15.6% $36M $160M
2021 $2.0B $70M 17.5% 5.3% $81M $73M
2020 $1.9B $107M 19.7% 7.8% $178M $96M
2019 $1.7B $113M 19.1% 8.8% $273M $240M
2018 $1.5B $76M 18.6% 6.5% $74M $99M
2017 $1.5B $90M 0.0% 9.0% $80M $7M
2016 $1.7B $123M 0.0% 11.8% $143M $14M

Valuation over time

How the market has priced ACA against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 27.9 55.7 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 1.2 2.5 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 0.2 0.3 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is ACA growing its revenue and profit?

Over the past 5 years, Arcosa, Inc.'s revenue has grown 8.3% per year, and net income grown 14.3% per year. These are computed facts, not advice.

How much debt does ACA have?

As of FY2025, Arcosa, Inc. reported — of total debt against $215M of cash; operating income covered interest expense 3.1×.

What is ACA's profit margin?

In FY2025, gross margin was 22.4%, operating margin 11.9%, and net margin 7.2%.

What is ACA's P/E ratio?

As of Jun '26, Arcosa, Inc. traded at a price-to-earnings ratio of about 34.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.